ArticleThoracic cancer2023

Comparison of neoadjuvant nab-paclitaxel plus immunotherapy versus paclitaxel plus immunotherapy for esophageal squamous cell carcinoma.

Yafan Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.